GO:FRAX,GarvanPOL-RISK

W Pluskiewicz1, A Werner2, M Bach2

  • 1Department and Clinic of Internal Diseases, Diabetology, and Nephrology, Metabolic Bone Diseases Unit, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 3-Maja 13/15 Street, 41-800, Katowice, Poland. wpluskiewicz@sum.edu.pl.

PubMed
概括

这项研究对457名女性的骨折风险评估工具FRAX,Garvan和POL-RISK进行了比较. 新的门提高了诊断的准确性,使得更好地识别需要骨质疏松症治疗的患者.